Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-13-000051)

Filing Details

Accession Number:: 0000885590-13-000051
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-13 17:35:59
Reporting Period:: 2013-06-11

Filing Date:: 2013-06-13
Accepted Time:: 2013-06-13 17:35:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1477123	Mitchell Lloyd Segal	2150 St. Elzear Blvd. West Laval A8 H7L 4A8		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2013-06-11	100	$86.44	340	No	4	P	Indirect	By Wife
Common Stock, No Par Value	Acquisiton	2013-06-11	90	$86.48	430	No	4	P	Indirect	By Wife
Common Stock, No Par Value	Acquisiton	2013-06-11	200	$86.45	630	No	4	P	Indirect	By Wife
Common Stock, No Par Value	Acquisiton	2013-06-11	300	$86.73	18,534	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2013-06-12	2,500	$83.50	21,034	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Wife
No	4	P	Indirect	By Wife
No	4	P	Indirect	By Wife
No	4	P	Direct
No	4	P	Direct

Footnotes

This number represents the actual price purchased, for all shares, in Canadian Dollars on the Toronto Stock Exchange.
This number represents common shares purchased and other equity awards that were previously reported in Table 1.
This number represents the actual price purchased, for all shares, in US Dollars on the New York Stock Exchange.